Potential conflicts of interest: Jeffrey D. Rothstein, MD, discloses that he was a consultant for GlaxoSmithKline; he served as an advisory board member for Cytokinetics, Inc.; he received research support from Ruxton Pharmaceuticals, Inc.; and he received honoraria from Merck & Co., Inc.
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis†
Article first published online: 3 FEB 2009
Copyright © 2009 American Neurological Association
Annals of Neurology
Supplement: Updates on Amyotrophic Lateral Sclerosis: Improving Patient Care
Volume 65, Issue Supplement 1, pages S3–S9, January 2009
How to Cite
Rothstein, J. D. (2009), Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol., 65: S3–S9. doi: 10.1002/ana.21543
- Issue published online: 12 FEB 2009
- Article first published online: 3 FEB 2009
- Manuscript Accepted: 5 SEP 2008
- Manuscript Revised: 4 JUN 2008
- Manuscript Received: 19 FEB 2008
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.